Drug maker Aurobindo Pharma on Wednesday said its wholly owned subsidiary, Apitoria Pharma, received a "Voluntary Action Indicated" classification for its Telangana API facility from the US health regulator.

The US Food and Drug Administration (US FDA) had inspected Unit-II, an active pharmaceutical ingredient (API) manufacturing facility of Apitoria Pharma Pvt Ltd, located at Gaddapotharam, Industrial Development Area — Kazipally Industrial Area, Jinnaram Mandal in Sangareddy District, Telangana, from September 7-15, 2026.